pioneer 6 oral semaglutide cardiovascular outcomes pioneer 6 results Post hoc analysis of SUSTAIN and trials suggests that people with type 2 diabetes at high risk treated with experience more stable kidney function compared with placebo PIONEER 6: Oral Semaglutide Passes
Description
Find in-network dietitians and nutritionists with minimal out-of-pocket costs
Start your journey to a healthier, more beautiful you today
Semaglutide, known in Canada under the brand names Ozempic, Wegovy, and Rybelsus, is a drug for the treatment of type 2 diabetes.
How did members who stayed on their medication fare with weight loss and program engagement
Methods We selected individuals aged 45 years and older already treated with metformin living in Lombardy, Italy, and then split them into two groups if they initiated GLP-1 RAs or other antidiabetic drugs, between 2019 and 2021
